India  

Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug

Video Credit: ANI - Duration: 01:26s - Published
Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug

Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug

Director of All India Institute of Medical Sciences (AIIMS) Delhi, Dr Randeep Guleria said that there are higher chances of toxicity if Hydroxychloroquine (HCQ) used as part of treatment for severe COVID-19 patients because of multiple drugs being used.

Being asked about his opinion on WHO 'temporarily' suspending clinical trials of HCQ for COVID-19, Dr Guleria said, "There are 2 different aspects, using Hydroxychloroquine as part of treatment for severe COVID-19 patients has higher chance that you may have toxicity because of multiple drugs being used.

And there are certain drugs which along with hydroxychloroquine can increase the chance of cardiac toxicity.

On the other hand, when we are giving it as prophylaxis or in mild illness and giving it alone the chances of side effects are much less.

We, as physicians have been using hydroxychloroquine for almost 30-40 years.

Patients have been using it daily, not for week but for months and years with no side effects.

So, when it is used judiciously, appropriately and not in combination with other drugs where the side effects can become much more, there is good suggestive data that suggests it is useful."

0
shares
ShareTweetSavePostSend
 


Tweets about this


Related videos from verified sources

‘Rise in India’s Covid cases not as high as other countries’: AIIMS director [Video]

‘Rise in India’s Covid cases not as high as other countries’: AIIMS director

AIIMS director Dr Randeep Guleria spoke on the Covid cases’ growth in India. Dr Guleria said the cases are rising but the numbers are still not as high as other countries. “The US has almost 40,000..

Credit: HT Digital Content     Duration: 01:45Published
AIIMS director explains why counting Covid deaths is more important than cases [Video]

AIIMS director explains why counting Covid deaths is more important than cases

AIIMS director Dr Randeep Guleria explains how controlling deaths caused by Covid-19 in India are more important than the spike in cases. Dr Guleria said that we have to consider the size of India’s..

Credit: HT Digital Content     Duration: 02:15Published
‘May not hit 5.5 lakh cases but…’: AIIMS director on Delhi’s Covid preparedness [Video]

‘May not hit 5.5 lakh cases but…’: AIIMS director on Delhi’s Covid preparedness

AIIMS director Dr Randeep Guleria spoke on the number of coronavirus cases in Delhi. Dr Guleria said the numbers in Delhi may not hit 5.5 lakh cases by July end. Earlier, Delhi government had said the..

Credit: HT Digital Content     Duration: 01:55Published